ranolazine has been researched along with Muscle Contraction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitchell, JR; Norman, J; Novak, KR; Pinter, MJ; Rich, MM | 1 |
| Bernard, CE; Beyder, A; Cima, RR; Dozois, EJ; Farrugia, G; Kline, CF; Kraichely, RE; Larson, DW; Mazzone, A; Mohler, PJ; Neshatian, L; Rhee, PL; Strege, PR | 1 |
| Aimond, F; Farah, C; Kong, L; Lacampagne, A; Pertuit, N; Reboul, C; Richard, S; Virsolvy, A | 1 |
3 other study(ies) available for ranolazine and Muscle Contraction
| Article | Year |
|---|---|
Sodium channel slow inactivation as a therapeutic target for myotonia congenita.
Topics: Acetanilides; Animals; Chloride Channels; Drug Delivery Systems; Mice; Mice, Transgenic; Muscle Contraction; Myotonia Congenita; Organ Culture Techniques; Piperazines; Ranolazine; Sodium Channel Blockers | 2015 |
Ranolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells.
Topics: Colon; Colon, Ascending; Constipation; HEK293 Cells; Humans; Muscle Contraction; Myocytes, Smooth Muscle; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Physical Stimulation; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Ranolazine | 2015 |
Antagonism of Nav channels and α1-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine.
Topics: Action Potentials; Adrenergic alpha-1 Receptor Antagonists; Animals; Aorta; Humans; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Ranolazine; Rats; Receptors, Adrenergic, alpha-1; Sodium Channel Blockers; Uterine Artery; Vasodilation; Voltage-Gated Sodium Channels | 2015 |